Rohan Mendonca
14Patents
3h-index
80Co-inventors
63Inventor score
Filing activity: Mar 15, 2000 → Jan 22, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8461328B2 | Tricyclic heterocyclic compounds, compositions and methods of use thereof | Chemistry; Metallurgy | 24 | Active |
| US6506733B1 | Compounds and compositions as protease inhibitors | Chemistry; Metallurgy | 17 | Expired |
| US8999998B2 | Pyrazolopyrimidine JAK inhibitor compounds and methods | Human Necessities | 4 | Active |
| US9346815B2 | 5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US10407424B2 | Naphthyridines as inhibitors of HPK1 | Chemistry; Metallurgy | 3 | Active |
| US10800780B2 | TDO2 Inhibitors | Human Necessities | 1 | Active |
| US9604984B2 | 5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US6525036B2 | Compounds and compositions as protease inhibitors | Chemistry; Metallurgy | 0 | Expired |
| US12297210B2 | Naphthyridine compounds and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11612606B2 | 8-aminoisoquinoline compounds and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11566003B2 | Isoquinolines as inhibitors of HPK1 | Chemistry; Metallurgy | 0 | Active |
| US11034692B1 | Naphthyridines as inhibitors of HPK1 | Chemistry; Metallurgy | 0 | Active |
| US11603373B2 | TDO2 and IDO1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US12378249B2 | Isoquinoline compounds and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.